FDA panel: Revoke drug's breast cancer approval

June 29, 2011 2:57:38 PM PDT
A panel of cancer experts has ruled for a second time that Avastin, the best-selling cancer drug in the world, should no longer be used in breast cancer patients, clearing the way for the government to remove its endorsement from the drug.